Replies to post #149 on Fresenius Kabi Pharmaceuticals (APCVZ)

[maninnepa]

what are u talking about??? here is a past PR about APP Pharmaceuticals...it is a subsidiary of Fresenius Kabi Pharmaceuticals Holding


market pulse
Oct. 8, 2009, 3:17 a.m. EDT · Recommend · Post:

Fresenius's APP gets a clearance for migraine drug

TEL AVIV (MarketWatch) -- APP Pharmaceuticals Inc. said on Thursday that the U.S. Food and Drug Administration cleared it to market sumatriptan succinate in pre-filled syringes. The drug is a generic version of GlaxoSmithKline's /quotes/comstock/13*!gsk/quotes/nls/gsk (GSK 38.57, -0.65, -1.66%) /quotes/comstock/23s!a:gsk (UK:GSK 1,287, +14.50, +1.14%) Imitrex, which treats migraine attacks. In February, APP, Schaumburg, Ill., was clear to market the drug in single-dose vials. APP is a subsidiary of Fresenius Kabi Pharmaceuticals Holding Inc., /quotes/comstock/15*!apcvz (APCV.Z 0.21, +0.03, +17.71%) which in turn is a unit of Fresenius SE, the Bad Homburg, Germany, health-care group

[MONEYMADE]

AP revenues $444M each yr.( We'll make our $1.23Bgoal easy!!!!)


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=48052996